Results 51 to 60 of about 1,548,047 (310)

Decision aids for people facing health treatment or screening decisions (Review) [PDF]

, 2009
Background Decision aids prepare people to participate in ’close call’ decisions that involve weighing benefits, harms, and scientific uncertainty. Objectives To conduct a systematic review of randomised controlled trials (RCTs) evaluating the efficacy ...
Adab, Armstrong, Auvinen, Auvinen, Barry, Bastian, Bekker, Bekker, Bekker, Bernstein, Briss, Brown, Brundage, Chadwick, Charles, Chewning, Clancy, Colella, Coulter, Crang-Svalenius, Davison, Davison, Deber, Deber, Degner, Deschamps, Deyo, Dodin, Dolan, Dunn, Elwyn, Emmett, Ende, Entwistle, Flood, Frosch, Frosch, Gafni, Gattellari, Gattellari, Godlee, Goel, Graham, Gravel, Green, Green, Green, Green, Greenfield, Gruppen, Gruppen, Hays, Healton, Herrera, Hewison, Hickish, Hochlehnert, Holloway, Holmes-Rovner, Hunt, Hunter, Hunter, Jadad, Johnson, Jorm, Kennedy, LaCroix, Lalonde, Laupacis, Lazcano Ponce, Legare, Lerman, Leung, Lewis, Llewellyn-Thomas, Maisels, Makoul, Man-Son-Hing, Manns, Markham, Martin, Maslin, Maslin, Mazur, McAlister, McBride, McGinley, McInerney-Leo, Michie, Miller, Molenaar, Molenaar, Montgomery, Morgan, Mulley, Mulley, Murray, Murray, Myers, Myers, Nagle, Newton, O'Cathain, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, Oakley, Partin, Pearson, Peele, Phelan, Phillips, Pignone, Proctor, Radloff, Ratliff, Rimer, Rimer, Roland, Roosmalen, Roosmalen, Rostom, Rothert, Rothert, Rovner, Ruland, Ryser, Schapira, Schwartz, Sepucha, Sheridan, Shorten, Sorenson, Spielberger, Stacey, Steiner, Stewart, Street, Street, Tabak, Thomson, Thornton, Valdez, Volk, Volk, Vuorma, Vuorma, Wagner, Wallston, Wang, Whelan, Whelan, Whitney, Willemsen, Wolf, Wolf, Wolf, Wong, Wroe, Zapka   +170 more
core   +3 more sources

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Combating Diabetes in Chittenden County: A Healthcare Provider Referral Campaign to Increase Patient Participation in the Vermont Diabetes Prevention Program [PDF]

, 2017
As of 2016, diabetes affects more than 29 million people in the United States and is the 7th leading cause of death nationwide. In Vermont, 1/10 people are diagnosed with either diabetes or prediabetes, with 6% of Vermonters affected by prediabetes and 5%
Magier, Samantha
core   +1 more source

Barriers to cardiac rehabilitation delivery in a low-resource setting from the perspective of healthcare administrators, rehabilitation providers, and cardiac patients [PDF]

, 2019
Background: Despite clinical practice guideline recommendations that cardiovascular disease patients participate, cardiac rehabilitation (CR) programs are highly unavailable and underutilized. This is particularly true in low-resource settings, where the
Britto, Raquel, da Silva, Lilian Pinto, Duarte Novais Silva, Luciana, Grace, Sherry L., Lima de Melo Ghisi, Gabriela, Lima, Márcia Maria Oliveira, Pereira, Danielle Aparecida Gomes, Sérvio, Thaianne Cavalcante   +7 more
core   +2 more sources

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine, Ofélie Trudeau‐Ferrin, Caroline Laverdière, Patrick Hamel, Rosanne Superstein, Bénédicte Koukoui, Carole Provost, Paul C. Nathan, Vijay Ramaswamy, Furqan Shaikh, Brenda Gallie, Ashwin Mallipatna, Stephanie Kletke, Helen Dimaras, Hallie Coltin   +14 more
wiley   +1 more source

A patient and community-centered approach selecting endpoints for a randomized trial of a novel advance care planning tool

Patient Preference and Adherence, 2018
John FP Bridges,1,2 Norah L Crossnohere,2 Anne L Schuster,1 Judith A Miller,3 Carolyn Pastorini,3,† Rebecca A Aslakson2,4,5 1Department of Health Policy and Management, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD ...
Bridges JFP, Crossnohere NL, Schuster AL, Miller JA, Pastorini C, Aslakson RA   +5 more
doaj  

Usability and feasibility of multimedia interventions for engaging patients in their care in the context of acute recovery: A narrative review

Health Expectations, 2019
Purpose The purpose of this narrative review was to examine the usability and feasibility of multimedia intervention as a platform to enable patient participation in the context of acute recovery and to discover what outcomes have been measured.
Jo McDonall, Anastasia F. Hutchinson, Bernice Redley, Patricia M. Livingston, Mari Botti   +4 more
doaj   +1 more source

Beyond Oncology: Question Prompt Lists in Healthcare—A Scoping Review Protocol

Methods and Protocols, 2020
Question prompt lists (QPL) are an instrument to promote patient participation in medical encounters by providing a set of questions patients can use during consultations. QPL have predominantly been examined in oncology. Less is known about their use in
Matthias Lukasczik, Christian Gerlich, Hans Dieter Wolf, Heiner Vogel   +3 more
doaj   +1 more source

Nurses’ Experiences Empowering Hospitalized Patients [PDF]

, 2017
Four focus groups were conducted to explore acute care nurses’ experiences empowering patients and the facilitators and barriers they encountered during the process.
Bull, Margaret J., Jerofke-Owen, Teresa
core   +2 more sources

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács, Zoltán Köllő, Balázs Gellért Karvaly, Mahmoud Obeidat, Rita Nagy, Péter Hegyi, Brigitta Teutsch, Eszter Tuboly, Miklós Garami   +8 more
wiley   +1 more source